Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice

  • Jansson M
  • Panoutsakopoulou V
  • Baker J
  • et al.
164Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Recent studies indicate that early T lymphocyte activation 1 (Eta-1), also known as osteopontin, is a cytokine contributing to the development of Th1 immunity. In the present report, the role of Eta-1 in experimental autoimmune encephalomyelitis (EAE), a disease associated with Th1 immunity, was examined by analysis of disease progression in Eta-1-deficient (Eta-1−/−) mice. Although incidence and onset of peptide-induced EAE were found to be similar in Eta-1−/− and Eta-1+/+ mice, Eta-1−/− mice displayed significantly lower mean maximal clinical score and faster recovery without spontaneous relapses. Accordingly, decreased inflammatory infiltration and demyelination were observed in the spinal cords of Eta-1−/− mice. Furthermore, in comparison to Eta-1+/+, Eta-1−/− CD4+ T cells had reduced expression of IFN-γ and TNF-α upon ex vivo restimulation. Taken together, these results suggest that Eta-1 may sustain autoimmune responses by assisting in maintenance of Th1 immunity during EAE.

Cite

CITATION STYLE

APA

Jansson, M., Panoutsakopoulou, V., Baker, J., Klein, L., & Cantor, H. (2002). Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice. The Journal of Immunology, 168(5), 2096–2099. https://doi.org/10.4049/jimmunol.168.5.2096

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free